The HIV Prevention Trials Network | Prevention Now
Biweekly Update 13-August 2021
1st IDI-sponsored Clinical Trial on HIV Treatment Published in NEJM - Makerere University News
Value-Added Use of Clinical Study Data: - ppt download
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus | NEJM
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus | NEJM
Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy | NEJM
J. Michael Ryan, MD (@JMichael_Ryan) / Twitter
PDF) A Cluster-Randomized Trial to Reduce Cesarean Delivery Rates in Quebec
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus | NEJM
Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery | NEJM
Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery | NEJM
PDF) Reduced Treatment Intensity In Patients With Early-Stage Hodgkin's Lymphoma
Evidence-based Practice in Infection Control and Prevention
Value-Added Use of Clinical Study Data: - ppt download
Frontiers | Gangliosides: Treatment Avenues in Neurodegenerative Disease
Is basic science disappearing from medicine? The decline of biomedical research in the medical literature - Steinberg - 2016 - The FASEB Journal - Wiley Online Library
Oscar Lahoud (@DrOscarLahoud) / Twitter
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
